Novartis malaria treatment Coartem® 80/480mg receives WHO prequalification, enabling greater access for patients

-Power of One campaign, supported by exclusive treatment sponsor Novartis, raises funds for three million treatments for children with malaria

-Novartis associates rallied behind Power of One to fund close to 500,000 antimalarial treatments for Zambia

-Company reaches delivery landmark with 700 million antimalarial treatments supplied without profit in 60 malaria-endemic countries since 2001

Novartis (http://www.novartis.com) announced today that, through Power of One, enough funds have...

-Novartis Access is a first-of-its-kind portfolio of products aimed at increasing access to medicines against cardiovascular diseases, diabetes, respiratory illnesses and breast cancer in low- and low-middle-income countries

-Program supports Kenyan government on noncommunicable disease (NCD) prevention and control – by 2030, NCDs are expected to cause more than 60% of deaths in the country1

-Agreements signed with Kenyan government and NGOs include programs to distribute medicines, raise...

.One million antimalarial treatments donated by Novartis, matching one million treatments funded through Malaria No More’s Power of One campaign

.Since 2009, Novartis has delivered over 600 million treatments without profit to malaria-endemic countries

.Today marks World Health Day, focusing on vector-borne diseases, of which malaria is the most deadly (1)

Novartis (NVS) (http://www.novartis.com) announced today that two million treatments of its pediatric antimalarial are arriving in...

Dr. Linus Igwemezie, Head of the Novartis Malaria Initiative.

 *Malaria experts and leaders from over 35 African countries gather to explore innovative strategies to move from malaria control to elimination

*Meeting convened by Novartis fosters best practice sharing and helps catalyze action to achieve new WHO objective of 90% reduction in malaria burden by 2030

*Growing threats including inadequate funding, first signs of drug resistance, and the advance of diseases such as Ebola, could...